Introduction:
The two commonly occurring viral infections in infants and young children are hand, foot, and mouth disease (HFMD) and Herpangina. Both diseases share some resemblances in their symptoms and can cause discomfort and distress. However, they are caused by different viruses and demonstrate distinct characteristics. This article explores the key differences between Herpangina and HFMD, including their causes, symptoms, treatments, and prevention measures.
What Is Herpangina?
Herpangina is a viral infection predominantly caused by Coxsackievirus group A, a member of the Enterovirus family. This highly contagious condition mainly affects children between three and ten years old. Its hallmark symptoms include the development of painful mouth sores and fever. The virus spreads through contact with an infected person's respiratory secretions or fecal matter.
-
Symptoms - Herpangina typically begins with a sudden onset of fever, often accompanied by a sore throat and headache. Within one to two days, small, painful, grayish-white ulcers develop at the back of the mouth, including the tonsils and the soft palate. These sores can make eating and drinking difficult, reducing appetite and dehydration in severe cases. The duration of Herpangina is usually about three to seven days, and most children recover without complications.
-
Treatment - Since a virus causes Herpangina, antibiotics are ineffective in treating the infection. Supportive care includes rest, staying hydrated, and providing pain relief through over-the-counter medications like acetaminophen or ibuprofen. Avoiding acidic, spicy, or rough foods can also help alleviate discomfort.
-
Prevention - To reduce the risk of Herpangina, proper hand hygiene is crucial, especially after coming into contact with an infected person or their belongings. Additionally, avoiding close contact with infected individuals can help prevent the spread of the virus.
What Is Hand, Foot, and Mouth Disease (HFMD)?
HFMD is a viral infection commonly occurring through infection by Enterovirus 71 (EV-71) and Coxsackievirus group A, where Coxsackievirus A16 is predominantly prevalent. While the disease significantly affects young children, it can also infect adults. HFMD is highly contagious and can be transmitted directly with respiratory secretions, feces, or contaminated surfaces.
Symptoms - HFMD typically starts with a fever, sore throat, and a general feeling of malaise. Within a day or two, small, painful sores or blisters develop on the palms of the hands, soles of the feet, and inside the mouth. These blisters may be red or grayish and can be accompanied by a rash. Unlike Herpangina, HFMD also affects the skin, which sets it apart.
The duration of HFMD is similar to Herpangina, lasting about three to seven days. Most patients recover without any complications.
Treatment - As with Herpangina, there is no specific treatment for HFMD. Supportive care is essential, focusing on relieving symptoms such as fever and discomfort. Over-the-counter pain medications and topical treatments for skin lesions can be used under the guidance of a healthcare professional.
Prevention - Preventing HFMD involves good hygiene practices, such as frequent handwashing, disinfecting commonly touched surfaces, and avoiding close contact with infected individuals. Additionally, keeping infected children home from school or daycare can help prevent the spread of the disease.
What Are the Key Differences Between Herpangina and HFMD?
Both conditions can cause mouth sores and are caused by enteroviruses, but their distribution and presentation differ.
-
Causative Agents: Herpangina is primarily caused by Coxsackievirus group A, whereas HFMD can be caused by Coxsackievirus A16 and Enterovirus 71 (EV-71).
-
Affected Areas: Herpangina mainly affects the mouth, causing painful ulcers at the back of the mouth and throat. In contrast, HFMD affects the mouth, hands, and feet, leading to blisters on the palms and soles.
-
Skin Involvement: Herpangina primarily affects the back of the mouth and throat, while HFMD involves not only the mouth but also the hands, feet, and sometimes the buttocks with the appearance of blisters.
-
Transmission: Both Herpangina and HFMD are highly contagious and spread through contact with respiratory secretions or fecal matter. However, HFMD may have a slightly higher potential for person-to-person transmission due to the involvement of skin lesions.
-
Common Age Group: Herpangina tends to affect slightly older children than HFMD, which is more common in infants and young children. Herpangina primarily affects children between three and ten years of age, while HFMD is most common in infants and young children up to five years old.
-
Topical Treatments: HFMD may benefit from using topical ointments or creams to manage skin lesions and blisters. These topical treatments are not applicable in Herpangina, as the condition is confined to the mouth.
-
Complications: Although both infections are generally mild and self-limiting, complications can rarely occur. These may include viral meningitis, encephalitis, or myocarditis. However, such complications are more commonly associated with EV-71-related HFMD.
-
Immunity and Reinfection: After recovering from Herpangina, individuals typically develop immunity to the specific strain of Coxsackievirus A that caused the infection. However, this immunity may not prevent infection from other strains or related viruses. In HFMD, individuals can be infected with different strains, and reinfections are possible.
-
Seasonal Variation: HFMD is known to exhibit seasonal variation, often peaking in the late summer and early autumn. Herpangina, on the other hand, may occur year-round without distinct seasonal patterns.
-
Geographic Distribution: Certain strains of HFMD, particularly those caused by Enterovirus 71 (EV-71), have been associated with more severe cases and outbreaks in different regions. The geographic distribution of these severe cases may vary, while Herpangina's impact tends to be more uniform.
Conclusion:
Herpangina and HFMD share similarities due to their viral origins, but they also have distinct characteristics in terms of clinical presentation, affected areas, transmission, and age group prevalence. Proper diagnosis and differentiation are crucial for appropriately managing and treating these viral infections. Both conditions typically resolve without complications, and supportive care forms the cornerstone of treatment. Ensuring proper hygiene practices and implementing preventive measures, like avoiding contact with infected individuals, can effectively lower the risk of transmission and safeguard susceptible populations from these viral infections. Monitoring for potential complications and providing supportive care is essential in promoting a swift recovery in affected individuals.
